Antibacterial activities of lactoferrin;Actividades antibacterianas de lactoferrina

Enfermedades Infecciosas y Microbiologia

Volumn 26, Issue 2, 2006, Pages 58-63

  Drago Serrano, María Elisa ^a  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Antibacterial agents; Innate defense; Iron binding proteins; Lactoferrin

Indexed keywords

EID: 61449086544     PISSN: 14050994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Baker EN, Baker HM. Molecular Structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 2005; 62: 2531-2539 (Pubitemid 41721228)
2. Vorland LH. Lactoferrin: A multifunctional glycoprotein. APMIS 1999; 107: 971-981
3. Levay PF, Viljoen M. Lactoferrin: A general review. Haematological 1995; 80: 252-267
4. Mayer L, Waker WA. "Development and physiology of mucosal defense: an Introduction". In Mucosal Immunology. Elsevier Academic Press, San Diego Calif. USA. Mestecky J, Lamm ME, McGhee JR, Bienenstock J, Mayer L, Strober W (Eds.). Part I, 3O Edition, 2005, cap.1: 5-18
5. Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004; 17: 189-196 (Pubitemid 38987136)
6. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005; 62: 2549-2559 (Pubitemid 41722207)
7. Reyes-Reyes RE, Manjarrez-Hernández HA, Drago-Serrano ME. El hierro y la virulencia bacteriana. Enf Inf Microbiol 2005; 25: 104-107
8. Dionysius DA, Grieve PA, Milne JM. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J Dairy Sci 1993; 76: 2597-2600
9. Dial EJ, Hall LR, Serna H, Romero JJ, Fox JG, Lichtenberger LM. Antibiotic properties of bovine lactoferrin on Helicobater pylori. Dig Dis Sci 1998; 43:2750-2756 (Pubitemid 29034932)
10. Goldoni P, Sinibaldi L, Valenti P, Orsi N. Metal complexes of lactoferrin and their effect on the intracellular multiplication of Legionella pneumophila. Biometals 2000;13:15-22 (Pubitemid 30243031)
11. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their susceptibility to tuberculosis. J Exp Med 2002; 196: 1507-1513 (Pubitemid 35424944)
12. Ogata T, Teraguchi S, Shin K, Kingaku M, Fukuwatari Y, Kawase K, Hayasawa H, Tomita M. The mechanism of in vivo bacteriostasis of bovine lactoferrin. Adv Exp Med Biol 1998; 443: 239-246 (Pubitemid 28432191)
13. Rogan MP, Taggart CC, Green CM, Murphy PC, O'Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to a decreased lactoferrin activity in patients with fibrosis cystic. J Infect Dis 2004; 190: 1245-1253 (Pubitemid 39287750)
14. Berlutti F, Ajello M, Bosso P, Morea C, Petrucca A, Antonini G, Valenti P. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 2004; 17: 271-278 (Pubitemid 38987149)
15. Sallmann FR, Baveye-Descamps S, Pattus F, Salmon V, Branza N, Spik G, Legrand D. Porins OmpC and PhoE of Escherichia coli as specific cell surface targets of human lactoferrin. Binding characteristics and biological properties. J Biol Chem 1999; 274: 16107-16114
16. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH. Lactoferrin is a Lipid A-binding protein. Infect Immun 1994; 62: 2628-2632 (Pubitemid 24157102)
17. Ellison RT, Laforce FM, Giehl TJ, Boose DS, Dunn BE. Lactoferrin and transferrin damage of the Gram negative outer membrane is modulated by Ca2+ and Mg2+. J Gen Microbiol 1990; 136: 1437-1446 (Pubitemid 20238484)
18. Naidu AS, Arnold RR. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility. Diag Microbiol Infect Dis 1994; 20: 69-75 (Pubitemid 24367334)
19. Ellison RT 3rd, Giehl TJ, La Force FM. Damage of the outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-2781 (Pubitemid 18259927)
20. Leitch EC, Willcox MD. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 1999; 48: 867-871 (Pubitemid 29476423)
21. Ochoa TJ, Noguera Obenza M, Ebel F, Guzmán CA, Gómez HF, Cleary TG. Lactoferrin impairs type III secretory system function in Enteropathogenic Escherichia coli. Infect Immun 2003; 71: 5149-5155 (Pubitemid 37070758)
22. Kawasaki Y, Tazume S, Shimizu K, Matsuzawa H, Dosako S, Isoda H, Tsukiji M, Fujimura R, Muranaka Y, Ishida H. Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells. Biosci Biotechnol Biochem 2000; 64: 348-354
23. Nascimento de Araujo A, Giugliano LG. Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. FEMS Microbiol Lett 2000; 184: 91-94 (Pubitemid 30109586)
24. Willer EM, Lima R de L, Giugliano LG. In vitro adhesion and invasion inhibition of Shigella dysentariae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins. BMC Microbiol 2004; 4: 18-24
25. Teraguchi S, Shin K, Fukuwatari Y, Shimamura. Glycans of bovine lactoferrin function as receptors for the type I fimbrial lectin of Escherichia coli. Infect Immun 1996; 64: 1075-1077 (Pubitemid 26065594)
26. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW 3rd, Plaut AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 1998; 95: 12641-12646 (Pubitemid 28483818)
27. Longhi C, Conte MP, Seganti L, Polidoro M, Alfsen A, Valenti P. Influence of HeLa lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in cells. Med Microbiol Immunol 1993;182:25-35 (Pubitemid 23085240)
28. Gómez HF, Ochoa TJ, Carlin LG, Cleary TG. Human lactoferrin impairs virulence of Shigella flexneri. J Infect Dis 2003;187: 87-95 (Pubitemid 36034475)
29. Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee BH, Kang PD, Kim YS, Park JH. Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice. J Med Microbiol 2005; 54: 1049-1054
30. Ochoa TJ, Clearly TG. Lactoferrin disruption of bacterial type III secretion systems. Biometals 2004; 17: 257-260 (Pubitemid 38987146)
31. Hendrixson DR, Qiu J, Shewry SC, Fink DL, Petty S, Baker EN, Plaut AG, St Geme III JW. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol 2003;47: 607-617 (Pubitemid 36114974)
32. Ohashi A, Murata E, Yamamoto K, Majima E, Sano E, Le QT, Katunuma N. New functions of lactoferrin and β-casein in mammalian milk as cysteine protease inhibitors.Biochem Biophys Res Commun 2003; 306: 98-103 (Pubitemid 36629410)
33. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005; 62: 2588-2598 (Pubitemid 41721232)
34. Dionysius DA, Milne JM. Antibacterial peptides of bovine lactoferrin: purification and characterization. J Dairy Sci 1997; 80: 667-674 (Pubitemid 127446978)
35. Vorland LH, Ulvatne H, Andersen J, Haukland H, Rekdal O, Svendsen JS, Gutteberg TJ. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998; 30: 513-517 (Pubitemid 29054360)
36. Yamauchi K, Tomita M, Giehl TJ, Ellison III RT. Antibacterial activity of lactoferrin and a pepsin derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719-728 (Pubitemid 23030865)
37. Shin K, Yamauchi K, Teraguchi S, Hayasawa H, Tomita M, Otsuka Y, Yamazaki S. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7. Lett Appl Microbiol 1998; 26: 407-411 (Pubitemid 28327903)
38. Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW. Structure function relationship of bacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111 Infect Immun 1998; 66: 2434-2440 (Pubitemid 28261735)
39. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK, Nuijens JH. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic resistant bacteria. Infect Immun 2001; 69: 1469-1476 (Pubitemid 32187596)
40. Håversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LÅ, Mattsby-Baltzer I. Human lactoferrin and peptides derived from surface exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 2000; 68: 5816-5823
41. Di Biase AM, Tinari A, Pietrantoni A, Antonini G, Valenti P, Conte MP, Superti F. Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol 2004; 53: 407-412 (Pubitemid 38586507)
42. Longhi C, Conte MP, Penta M, Cossu A, Antonini G, Superti F, Seganti L. Lactoferricin influences early events of Listeria monocytogenes infection in THP-1 human macrophages. J Med Microbiol 2004; 53:87-91 (Pubitemid 38223684)
43. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 2002; 80:109-112 (Pubitemid 34194235)
44. Lonnerdal B. Human milk proteins: key components for the biological activity of human milk. Adv Exp Med Biol 2004; 554:11-25 (Pubitemid 39304499)